Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
PFE has been in the news recently: Kyntra Bio Inc. announced fluctuating shares after releasing Phase 1b/2 study data for FG-3246 combined with enzalutamide for prostate cancer treatment. Meanwhile, investors are showing strong interest in Pfizer, as significant investments are being directed towards the company.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.